Typical RTT cases arise from de novo loss-of-function mutations in the MECP2 gene encoding the Methyl-CpG-binding protein 2 (MECP2) (Amir et al., 1999), a global transcriptional regulator. Here, MECP2 is linked to Rett syndrome.